Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.25072
Abstract: Key Points Question Is radioactive iodine (RAI) therapy for hyperthyroidism associated with an increased cancer risk? Findings This systematic review and meta-analysis, including 12 observational studies and 479 452 participants, found that RAI therapy was not… read more here.
Keywords: cancer; cancer risk; hyperthyroidism; rai therapy ... See more keywords
Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer
Sign Up to like & getrecommendations! Published in 2017 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000000756
Abstract: Objective Prophylactic central neck dissection (pCND) is controversial in papillary thyroid carcinoma (PTC) without clinical positive lymph nodes. The aim of this study was to investigate the effect of radioactive iodine (RAI) therapy on the… read more here.
Keywords: rai therapy; pcnd; response; group ... See more keywords
The BRAFV600E mutation in papillary thyroid microcarcinoma with intermediate-risk to high-risk features: does the mutation have an effect on clinical response to radioiodine therapy?
Sign Up to like & getrecommendations! Published in 2019 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000000930
Abstract: Objectives Preclinical studies showed that BRAFV600E mutation significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy. However, clinical data regarding its role in therapeutic decision making with respect to RAI therapy… read more here.
Keywords: rai therapy; clinical response; risk; mutation ... See more keywords
Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer: A Pilot Study.
Sign Up to like & getrecommendations! Published in 2025 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000006146
Abstract: BACKGROUND Radioactive iodine (RAI) therapy is the standard-of-care for metastatic differentiated thyroid cancer (DTC), but ~60% of patients show resistance before achieving satisfactory response. METHODS Eligible patients were randomly assigned to RAI therapy plus lenvatinib… read more here.
Keywords: rai; metastatic differentiated; rai arm; rai therapy ... See more keywords
FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0218416
Abstract: Background In some patients with metastatic differentiated thyroid cancer, even if they had substantial of radioactive iodine (RAI) uptake, the RAI therapy response was poor. We investigated the usefulness of FDG PET/CT for the early… read more here.
Keywords: rai; rai therapy; response; fdg pet ... See more keywords
Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis
Sign Up to like & getrecommendations! Published in 2025 at "European Thyroid Journal"
DOI: 10.1530/etj-24-0341
Abstract: Introduction This case report aims to discuss the development of fatal lung fibrosis in a young boy following treatment of metastasized differentiated thyroid carcinoma (DTC). Case presentation A 3.6-year-old boy was diagnosed in year 1995… read more here.
Keywords: rai therapy; fatal lung; lung; lung fibrosis ... See more keywords
Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes and Recurrence Risk Categories
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Nuclear Medicine"
DOI: 10.2967/jnumed.124.269091
Abstract: Visual Abstract For patients with differentiated thyroid cancer (DTC), that is, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), the American Thyroid Association and European Thyroid Association generally recommend radioactive iodine (RAI) therapy after… read more here.
Keywords: survival; relative survival; risk; thyroid ... See more keywords
Comparing therapeutic outcomes: radioactive iodine therapy versus non-radioactive iodine therapy in differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2024.1442714
Abstract: Introduction Radioactive iodine (RAI) has been utilized for nearly 80 years in treating both hyperthyroidism and thyroid cancer, and it continues to play a central role in the management of differentiated thyroid cancer (DTC) today.… read more here.
Keywords: radioactive iodine; iodine therapy; therapy; control ... See more keywords
An immediate postoperative response to therapy assessment can help avoid unnecessary RAI therapy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.947710
Abstract: Background Radioiodine (RAI) therapy plays a vital role in the postoperative treatment of differentiated thyroid cancer (DTC) patients underwent total thyroidectomy (TT). However, even in the presence of capsular invasion and lymph node metastasis prognosis… read more here.
Keywords: rai therapy; therapy; response therapy; response ... See more keywords
Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
Sign Up to like & getrecommendations! Published in 2022 at "Endocrinology and Metabolism"
DOI: 10.3803/enm.2022.1418
Abstract: Background Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate. Therefore, many patients require repeated… read more here.
Keywords: 2nd rai; radioactive iodine; rai therapy; therapy ... See more keywords